QIAGEN Revenue 2006-2019 | QGEN

QIAGEN annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • QIAGEN revenue for the quarter ending September 30, 2019 was $0.383B, a 1.26% increase year-over-year.
  • QIAGEN revenue for the twelve months ending September 30, 2019 was $1.516B, a 1.38% increase year-over-year.
  • QIAGEN annual revenue for 2018 was $1.502B, a 5.95% increase from 2017.
  • QIAGEN annual revenue for 2017 was $1.418B, a 5.95% increase from 2016.
  • QIAGEN annual revenue for 2016 was $1.338B, a 4.45% increase from 2015.
QIAGEN Annual Revenue
(Millions of US $)
2018 $1,502
2017 $1,418
2016 $1,338
2015 $1,281
2014 $1,345
2013 $1,302
2012 $1,254
2011 $1,170
2010 $1,087
2009 $1,010
2008 $893
2007 $650
2006 $466
2005 $398
QIAGEN Quarterly Revenue
(Millions of US $)
Q3 2019 $383
Q2 2019 $382
Q1 2019 $349
Q4 2018 $403
Q3 2018 $378
Q2 2018 $377
Q1 2018 $344
Q4 2017 $397
Q3 2017 $364
Q2 2017 $349
Q1 2017 $308
Q4 2016 $367
Q3 2016 $339
Q2 2016 $334
Q1 2016 $298
Q4 2015 $349
Q3 2015 $315
Q2 2015 $319
Q1 2015 $298
Q4 2014 $360
Q3 2014 $336
Q2 2014 $331
Q1 2014 $317
Q4 2013 $361
Q3 2013 $322
Q2 2013 $315
Q1 2013 $304
Q4 2012 $347
Q3 2012 $304
Q2 2012 $307
Q1 2012 $296
Q4 2011 $334
Q3 2011 $289
Q2 2011 $282
Q1 2011 $264
Q4 2010 $286
Q3 2010 $274
Q2 2010 $263
Q1 2010 $264
Q4 2009 $289
Q3 2009 $260
Q2 2009 $240
Q1 2009 $221
Q4 2008 $237
Q3 2008 $231
Q2 2008 $218
Q1 2008 $207
Q4 2007 $210
Q3 2007 $177
Q2 2007 $135
Q1 2007 $128
Q4 2006 $126
Q3 2006 $118
Q2 2006 $113
Q1 2006 $109
Q4 2005 $104
Q3 2005 $99
Q2 2005 $100
Q1 2005 $95
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.593B $1.502B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.308B 15.93
CSL (CSLLY) Australia $85.405B 0.00
Gilead Sciences (GILD) United States $83.588B 10.36
Vertex Pharmaceuticals (VRTX) United States $56.863B 58.04
Biogen (BIIB) United States $52.454B 9.00
Illumina (ILMN) United States $47.477B 52.09
Regeneron Pharmaceuticals (REGN) United States $40.493B 17.73
Alexion Pharmaceuticals (ALXN) United States $25.238B 12.46
Seattle Genetics (SGEN) United States $20.383B 0.00
Incyte (INCY) United States $20.269B 47.05
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.513B 64.10
BioMarin Pharmaceutical (BMRN) United States $14.411B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.643B 0.00
Galapagos (GLPG) Belgium $11.053B 28.48
Exact Sciences (EXAS) United States $10.807B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
BeiGene (BGNE) Cayman Islands $9.600B 0.00
Sarepta Therapeutics (SRPT) United States $8.297B 0.00
Bio-Techne Corp (TECH) United States $8.214B 54.98
Amarin (AMRN) Ireland $7.727B 0.00
Moderna (MRNA) United States $7.092B 0.00
Guardant Health (GH) United States $7.062B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.922B 0.00
Medicines (MDCO) United States $6.705B 0.00
Reata Pharmaceuticals (RETA) United States $6.134B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.042B 15.36
ARGENX SE-ADR (ARGX) Netherlands $5.609B 0.00
Exelixis (EXEL) United States $5.065B 14.25
Ascendis Pharma (ASND) Denmark $4.793B 0.00
Bluebird Bio (BLUE) United States $4.696B 0.00
China Biologic Products (CBPO) China $4.597B 25.90
Repligen (RGEN) United States $4.570B 82.82
Spark Therapeutics (ONCE) United States $4.272B 0.00
Mirati Therapeutics (MRTX) United States $4.133B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.037B 0.00
MorphoSys AG (MOR) Germany $3.985B 0.00
Blueprint Medicines (BPMC) United States $3.775B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.728B 0.00
Immunomedics (IMMU) United States $3.674B 0.00
Adaptive Biotechnologies (ADPT) United States $3.353B 0.00
Alkermes (ALKS) Ireland $3.191B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
MyoKardia (MYOK) United States $3.029B 0.00
UniQure (QURE) Netherlands $2.788B 0.00
Emergent Biosolutions (EBS) United States $2.770B 27.52
Halozyme Therapeutics (HALO) United States $2.739B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 0.00
NeoGenomics (NEO) United States $2.670B 142.06
Acceleron Pharma (XLRN) United States $2.593B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.401B 0.00
Zai Lab (ZLAB) China $2.354B 0.00
Arena Pharmaceuticals (ARNA) United States $2.301B 5.35
RA PHARMCTL INC (RARX) United States $2.215B 0.00
Insmed (INSM) United States $2.052B 0.00
Ligand Pharmaceuticals (LGND) United States $1.950B 37.50
Myriad Genetics (MYGN) United States $1.843B 27.23
Dicerna Pharmaceuticals (DRNA) United States $1.771B 0.00
Denali Therapeutics (DNLI) United States $1.702B 0.00
Zymeworks (ZYME) Canada $1.695B 0.00
REGENXBIO (RGNX) United States $1.638B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.634B 0.00
Akcea Therapeutics (AKCA) United States $1.623B 0.00
Editas Medicine (EDIT) United States $1.554B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.520B 0.00
Epizyme (EPZM) United States $1.448B 0.00
Alector (ALEC) United States $1.340B 0.00
Sangamo Therapeutics (SGMO) United States $1.318B 0.00
Innoviva (INVA) United States $1.314B 3.87
Arvinas (ARVN) United States $1.271B 0.00
Athenex (ATNX) United States $1.239B 0.00
Coherus BioSciences (CHRS) United States $1.226B 0.00
WAVE Life Sciences (WVE) Singapore $1.169B 0.00
Principia Biopharma (PRNB) United States $1.156B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.141B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Fate Therapeutics (FATE) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $0.974B 0.00
Revance Therapeutics (RVNC) United States $0.909B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.908B 7.64
ZIOPHARM Oncology Inc (ZIOP) United States $0.889B 0.00
Codexis (CDXS) United States $0.888B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
Precision BioSciences (DTIL) United States $0.856B 0.00
Pharming Group (PHGUF) Netherlands $0.840B 0.00
Vericel (VCEL) United States $0.836B 311.83
Intellia Therapeutics (NTLA) United States $0.834B 0.00
Anika Therapeutics (ANIK) United States $0.812B 26.34
MiMedx (MDXG) United States $0.797B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
Twist Bioscience (TWST) United States $0.748B 0.00
Heska (HSKA) United States $0.746B 190.58
ANI Pharmaceuticals (ANIP) United States $0.720B 12.27
Adverum Biotechnologies (ADVM) United States $0.691B 0.00
DBV Technologies S.A (DBVT) France $0.688B 0.00
Cara Therapeutics (CARA) United States $0.678B 0.00
UROGEN PHARMA (URGN) United States $0.660B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.650B 0.00
Clovis Oncology (CLVS) United States $0.640B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.629B 0.00
Mesoblast (MESO) Australia $0.616B 0.00
Cellectis S.A (CLLS) France $0.614B 0.00
Sorrento Therapeutics (SRNE) United States $0.614B 0.00
GENFIT S.A (GNFT) France $0.606B 0.00
BioDelivery Sciences (BDSI) United States $0.605B 0.00
Cytokineticsorporated (CYTK) United States $0.578B 0.00
Retrophin (RTRX) United States $0.564B 0.00
Agenus (AGEN) United States $0.552B 0.00
PHARMA MAR SA (PHMMF) Spain $0.549B 0.00
Kadmon Holdings (KDMN) United States $0.542B 0.00
Intra-Cellular Therapies (ITCI) United States $0.537B 0.00
AC Immune SA (ACIU) Switzerland $0.535B 12.38
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Stemline Therapeutics (STML) United States $0.502B 0.00
Prothena (PRTA) Ireland $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.387B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
Puma Biotechnology (PBYI) United States $0.364B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
PDL BioPharma (PDLI) United States $0.354B 8.86
OSMOTICA PHARM (OSMT) United States $0.351B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.351B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 2.43
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.338B 0.00
Pfenex (PFNX) United States $0.334B 0.00
Avid Bioservices (CDMO) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.312B 0.00
Geron (GERN) United States $0.300B 0.00
Kindred Biosciences (KIN) United States $0.299B 0.00
CytomX Therapeutics (CTMX) United States $0.288B 0.00
Kamada (KMDA) Israel $0.287B 8.38
Cue Biopharma (CUE) United States $0.276B 0.00
Compugen (CGEN) Israel $0.274B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Albireo Pharma (ALBO) United States $0.266B 0.00
Seres Therapeutics (MCRB) United States $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.258B 0.00
Inovio Pharmaceuticals (INO) United States $0.255B 0.00
MannKind (MNKD) United States $0.254B 0.00
Scholar Rock Holding (SRRK) United States $0.246B 0.00
Exicure (XCUR) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Biofrontera AG (BFRA) Germany $0.232B 0.00
Theratechnologies (THTX) Canada $0.231B 0.00
Spero Therapeutics (SPRO) United States $0.215B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
ChromaDex (CDXC) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
Athersys (ATHX) United States $0.205B 0.00
Syros Pharmaceuticals (SYRS) United States $0.203B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.200B 0.00
Mersana Therapeutics (MRSN) United States $0.194B 0.00
Senesco Technologies (ELOX) United States $0.193B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.193B 0.00
Affimed (AFMD) Germany $0.186B 0.00
Palatin Technologies (PTN) United States $0.183B 4.99
IVERIC Bio (ISEE) United States $0.172B 0.00
ARAVIVE, INC (ARAV) United States $0.169B 0.00
Dyadic (DYAI) United States $0.168B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.159B 0.00
Cerecor (CERC) United States $0.157B 0.00
CorMedix Inc (CRMD) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.152B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
Alcobra (ARCT) United States $0.145B 0.00
TELA Bio (TELA) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.140B 0.00
NantKwest (NK) United States $0.139B 0.00
Prometic Life Sciences (LMNL) Canada $0.137B 0.00
Proteostasis Therapeutics (PTI) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.132B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Protagonist Therapeutics (PTGX) United States $0.128B 0.00
Novavax (NVAX) United States $0.127B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Arsanis (XFOR) United States $0.126B 0.00
Celyad SA (CYAD) Belgium $0.122B 0.00
BioTime (LCTX) United States $0.120B 6.15
AVEO Pharmaceuticals (AVEO) United States $0.119B 0.00
Arbutus Biopharma (ABUS) Canada $0.114B 0.00
Verastem (VSTM) United States $0.106B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Emmaus Life Sciences (EMMA) United States $0.104B 0.00
OvaScience (MLND) United States $0.103B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.099B 2.65
Acorda Therapeutics (ACOR) United States $0.099B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.099B 0.00
Aduro Biotech (ADRO) United States $0.095B 0.00
Adocia (ADOCY) France $0.086B 0.00
Antibe Therapeutics (ATBPF) Canada $0.084B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Liquidia Technologies (LQDA) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.047B 0.00
Orgenesis (ORGS) United States $0.047B 3.03
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Evogene (EVGN) Israel $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
BioCardia (BCDA) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Aptevo Therapeutics (APVO) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Soligenix (SNGX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
VistaGen Therapeutics (VTGN) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Advaxis (ADXS) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
IBio (IBIO) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.003B 0.00